Pembrolizumab is safe and effective and substantially increases overall survival in aNSCLC patients

Pembrolizumab is safe and effective and substantially increases overall survival in aNSCLC patients

ecancer

5 лет назад

1,875 Просмотров

Ссылки и html тэги не поддерживаются


Комментарии: